Rascaltherapeutics
1 known investors
RasCal Therapeutics develops targeted cancer therapies aimed at previously "untargetable" mutations that drive some of the deadliest cancers, using novel mechanisms intended to work alongside conventional treatments, targeted therapies, and immunotherapies. The company is conducting human clinical trials of its lead anti-cancer compound.
Investors · 1
Frequently asked questions
- What does Rascaltherapeutics do?
- RasCal Therapeutics develops targeted cancer therapies aimed at previously "untargetable" mutations that drive some of the deadliest cancers, using novel mechanisms intended to work alongside conventional treatments, targeted therapies, and immunotherapies. The company is conducting human clinical trials of its lead anti-cancer compound.
- Who are Rascaltherapeutics's investors?
- Rascaltherapeutics's investors include TSVC.